La Jolla, CA, United States of America

Sungsoon Fang

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: The Salk Institute, The University of Sydney. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sungsoon Fang. Retrieved from https://idiyas.com/inventor/sungsoon-fang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Sure, let's create an article about inventor Sungsoon Fang.

Title: The Innovator Extraordinaire - Sungsoon Fang

Introduction:

In the innovative landscape of La Jolla, CA, Sungsoon Fang stands out as a prolific inventor with a keen focus on advancements in pharmaceuticals and treatments for metabolic disorders. With a notable track record and a total of 4 patents to his name, Sungsoon Fang's contributions to the field are a testament to his dedication to scientific progress.

Latest Patents:

Sungsoon Fang's latest patents revolve around the development of analogs of fexaramine and their methods of manufacturing and utilization. These novel compounds and compositions play a crucial role in treating and preventing metabolic disorders by activating FXR receptors in the intestines. Additionally, they are instrumental in addressing inflammation in the intestinal region, showcasing Fang's innovative approach to combatting health challenges.

Career Highlights:

Having worked at prestigious institutions like The Salk Institute for Biological Studies and The University of Sydney, Sungsoon Fang has honed his expertise in molecular biology and pharmacology. His quest for groundbreaking solutions in the medical field has led to the successful patenting of inventive pharmaceutical compounds that have the potential to revolutionize treatments for various health conditions.

Collaborations:

During his career, Sungsoon Fang has collaborated with esteemed professionals such as Ronald Mark Evans and Michael Downes. These partnerships have fueled his inventive spirit and facilitated the development of cutting-edge pharmaceutical formulations aimed at enhancing human health and well-being.

Conclusion:

In conclusion, Sungsoon Fang's innovative prowess shines through his patents and collaborative efforts in the realm of pharmaceutical research. His relentless dedication to advancing medical science serves as an inspiration to aspiring inventors and underscores the importance of pushing the boundaries of innovation in pursuit of a healthier future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…